Exploration of the binding of DNA binding ligands to Staphylococcal DNA through QM/MM docking and molecular dynamics simulation

Journal of Biomolecular Structure and Dynamics

Volumn 31, Issue 6, 2013, Pages 561-571

  Vijayalakshmi, Periyasamy ^a   Selvaraj, Chandrabose ^b   Singh, Sanjeev Kumar ^b   Nisha, Jaganathan ^a   Saipriya, Kandasamy ^a   Daisy, Pitchai ^a  

^a HOLY CROSS COLLEGE   (India)

^b ALAGAPPA UNIVERSITY   (India)

Author keywords

DNA binding ligands and Staphylococcus; DNA docking; DNA gyrase; QM MM

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; DNA BINDING LIGAND; DNA TOPOISOMERASE (ATP HYDROLYSING); UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL REPRODUCTION; BINDING AFFINITY; DNA BINDING; DNA DRUG COMPLEX; DNA REPLICATION; MOLECULAR DOCKING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; STAPHYLOCOCCUS;

BINDING SITES; DNA; DNA REPLICATION; DNA, BACTERIAL; LIGANDS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; NUCLEIC ACID CONFORMATION; PROTEIN CONFORMATION; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS;

EID: 84878710622     PISSN: 07391102     EISSN: 15380254     Source Type: Journal    
DOI: 10.1080/07391102.2012.706080     Document Type: Article

References (42)

1. Blackburn, G.M. 1996. " DNA and RNA Structure (2nd ed.) ". In Nucleic acids in chemistry and biology, Edited by: Blackburn, G.M. and Gait, M.J. 15-81. New York, NY: Oxford University Press.
2. Boger, D.L., Fink, B.E., and, Hedrick, M.P. 2000. Total synthesis of distamycin A and 2640 analogues: A solution-phase combinatorial approach to the discovery of new, bioactive DNA binding agents and development of a rapid, high-throughput screen for determining relative DNA binding affinity or DNA binding sequence selectivity. Journal of the American Chemical Society, 122 (27): 6382-6394. doi: 10.1021/ja994192d
3. Centers for Disease Control and Prevention Community associated MRSA: Frequently asked questions (2003a, August). Centers for Disease Control and Prevention, Atlanta. Retrieved from http://www.cdc.gov/ncidod
4. Centers for Disease Control and Prevention. Community associated MRSA: Fact sheet (2003b, February). Centers for Disease Control and Prevention, Atlanta. Retrieved from http://www.cdc.gov/ncidod
5. Chambers, H.F. 2005. Community-associated MRSA resistance and virulence converge. The New England Journal of Medicine, 352: 1485-1487. http://www.nejm.org/doi/full/10.1056/NEJMe058023
6. Dearden, J.C. 2003. In silico prediction of drug toxicity. Journal of Computer-Aided Molecular Design, 17: 119-127. doi: 10.1023/A:1025361621494
7. Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., and, Blanche, F. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: A primary target of fluoroquinolones. Molecular Microbiology, 13 (4): 641-653. doi: 10.1111/j.1365-2958.1994.tb00458.x
8. Franklin, D., and, Lowy, M.D. 1998. Staphylococcus aureus infections. The New England Journal of Medicine, 339: 520-532. http://www.nejm.org/doi/full/10. 1056/NEJM199808203390806
9. Friesner, R.A., Banks, J.L., Murphy, R.B., Halgren, T.A., Klicic, J.J., Mainz, D.T.,., and, Shenkin, P.S. 2004. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47 (7): 1739-1749. doi: 10.1021/jm0306430
10. Ge, Y., Difuntorum, S., Touami, S., Critchley, I., Bürli, R., Jiang, V.,., and, Moser, H. 2002. In vitro antimicrobial activity of GSQ1530, a new heteroaromatic polycyclic compound. Antimicrobial Agents and Chemotherapy, 46 (10): 3168-3174. doi: 10.1128/AAC.46.10.3168-3174.2002
11. Hodgson, J. 2001. ADMET-turning chemicals into drugs. Nature Biotechnology, 19 (8): 722-726. doi: 10.1038/90761
12. Ikeguchi, M. 2004. Partial rigid-body dynamics in NPT, NPAT and NPgammaT ensembles for proteins and membranes. Journal of Computational Chemistry, 25 (4): 529-541. doi: 10.1002/jcc.10402
13. Jacobson, M.P., Kaminski, G.A., Friesner, R.A., and, Rapp, C.S. 2002. Force field validation using protein side chain prediction. The Journal of Physical Chemistry B, 106: 11673-11680. doi: 10.1021/jp021564n
14. Jaguar version 7.8, Schrödinger, LLC., New York, NY.
15. Kaizerman, J.A., Gross, M.I., Ge, Y., White, S., Hu, W., Duan, J.X.,., and, Bürli, R.W. 2003. DNA binding ligands targeting drug-resistant bacteria: Structure, activity, and pharmacology. Journal of Medicinal Chemistry, 46 (18): 3914-3929. doi: 10.1021/jm030097a
16. Kevin, J.B., Edmond, C., Huafeng, X., Ron, O.D., Michael, P.E., Brent, A.G.,. David, E.S. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the 2006 ACM/IEEE Conference on Supercomputing. ACM, Tampa.
17. Kleinerman, D.S., Czaplewski, C., Liwo, A., and, Scheraga, H.A. 2008. Implementations of Nosé-Hoover and Nosé-Poincaré thermostats in mesoscopic dynamic simulations with the united-residue model of a polypeptide chain. Journal of Chemical Physics, 128 (24): 245103-1-245103-16. doi: 10.1063/1.2943146
18. Kopka, M.L., Goodsell, D.S., Han, G.W., Chiu, T.K., Lown, J.W., and, Dickerson, R.E. 1997. Defining GC-specificity in the minor groove: Side-by-side binding of the di-imidazole lexitropsin to C-A-T-G-G-C-C-A-T-G. Structure, 5 (8): 1033-1046. doi: 10.1016/S0969-2126(97)00255-4
19. LigPrep (2.5) [Schrödinger, LLC]. New York, NY.
20. Lindsay, J.A., and, Holden, M.T. 2006. Understanding the rise of the superbug: Investigation of the evolution and genomic variation of Staphylococcus aureus. Functional & Integrative Genomics, 6 (3): 186-201. doi: 10.1007/s10142-005-0019-7
21. Lipinski, C.A., Lombardo, F., Dominy, B.W., and, Feeney, P.J. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46: 3-26. http://dx.doi.org/10.1016/S0169-409X(96)00423-1
22. Liu, L.F., and, Wang, J.C. 1978. DNA-DNA gyrase complex: The wrapping of the DNA duplex outside the enzyme. Cell, 979-984. 10.1016/0092-8674(78)90281-7
23. Maestro (9.2) [Schrödinger, LLC]. New York, NY.
24. Marvin Draw (5.1.5) [Chemaxon Ltd]. Budapest.
25. Maxwell, A. 1997. DNA gyrase as a drug target. Trends in Microbiology, 5 (3): 102-109. http://dx.doi.org/10.1016/S0966-842X(96)10085-8
26. Mdluli, K., and, Ma, Z. 2007. Mycobacterium tuberculosis DNA gyrase as a target for drug discovery. Infectious Disorders-Drug Targets, 2: 159-168. http://www.benthamdirect.org/pages/content.php?IDDT/2007/00000007/00000002/ 0008S.SGM
27. Merlot, C. 2010. Computational toxicology-a tool for early safety evaluation. Drug Discovery Today, 15: 16-22. http://dx.doi.org/10.1016/j.drudis. 2009.09.010
28. Morávek, Z., Neidle, S., and, Schneider, B. 2002. Protein and drug interactions in the minor groove of DNA. Nucleic Acids Research, 30 (5): 1182-1191. doi: 10.1093/nar/30.5.1182
29. Munde, M., Ismail, M.A., Arafa, R., Peixoto, P., Collar, C.J., Liu, Y.,., and, Wilson, W.D. 2007. Design of DNA minor groove binding diamidines that recognize GC base pair sequences: A dimeric-hinge interaction motif. Journal of the American Chemical Society, 129 (44): 13732-13743. doi: 10.1021/ja074560a
30. NABI Biopharmaceuticals Key facts about S. aureus infections (2007, April 10) NABI Biopharmaceuticals, Miami. Retrieved from http://www.nabi.com
31. Palchaudhuri, P., and, Hergenrother, P.J. 2007. DNA as a target for anticancer compounds: Methods to determine the mode of binding and the mechanism of action. Current Opinion in Biotechnology, 6: 497-503. http://dx.doi.org/10. 1016/j.copbio.2007.09.006
32. Prival, M.J. 2001. Evaluation of the TOPKAT system for predicting the carcinogenicity of chemicals. Environmental and Molecular Mutagenesis, 37 (1): 55-69. doi: 10.1002/1098-2280(2001) 37:1<55::AID-EM1006>3.0.CO;2-5
33. QikProp (3.4) [Schrödinger, LLC]. New York, NY.
34. QM-Polarized Ligand Docking protocol; Glide version 5.7, Schrödinger, LLC., New York, NY.
35. Richard, A.M. 1998. Commercial toxicology prediction systems: A regulatory perspective. Toxicology Letters, 102-103: 611-616. http://dx.doi.org/10.1016/S0378-4274(98)00257-4
36. Sengupta, D., Verma, D., and, Naik, P.K. 2007. Docking mode of delvardine and its analogues into the p66 domain of HIV-1 reverse transcriptase: Screening using molecular mechanics-generalized born/surface area and absorption, distribution, metabolism and excretion properties. Journal of Biosciences, 32 (7): 1307-1316. http://www.springerlink.com/content/d323x7865421j4g0/
37. Sitemap (2.5) [Schrödinger, LLC]. New York, NY.
38. Sivaraman, K., Venkataraman, N., and, Cole, A.M. 2009. Staphylococcus aureus nasal carriage and its contributing factors. Future Microbiology, 4 (8): 999-1008. doi: 10.2217/fmb.09.79
39. Tejerina, C., Reig, A., Codina, J., Safont, J., Baena, P., and, Mirabet, V. 1992. An epidemiological study of burn patients hospitalized in Valencia, Spain, during 1989. Burns, 18: 15-18. http://dx.doi.org/10.1016/0305-4179(92) 90112-8
40. Van de Waterbeemd, H., and, Gifford, E. 2003. ADMET in silico modelling: Towards prediction paradise. Nature Reviews Drug Discovery, 2: 192-204. doi: 10.1038/nrd1032
41. Wahle, E., and, Kornberg, A. 1988. The partition locus of plasmid pSC101 is a specific binding site for DNA gyrase. The EMBO Journal, 7 (6): 1889-1895. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC457182/pdf/emboj00143-0313.pdf
42. Zhang, C., Rauge, S., Eisenberg, B., and, Carloni, P. 2010. Molecular dynamics in physiological solutions: Force fields, alkali metal ions, and ionic strength. Journal of Chemical Theory and Computation, 6: 2167-2175. doi: 10.1021/ct9006579